查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1888623

全球下一代定序服務市場：市場規模、佔有率和趨勢分析（按服務類型、工作流程、最終用途和地區分類），細分市場預測（2025-2033 年）

Next-generation Sequencing Services Market Size, Share & Trends Analysis Report By Service Type (Human Genome Sequencing, Gene Regulation Services), By Workflow, By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

下一代定序服務市場概覽

全球次世代定序服務市場規模預計在2024年達到66.6億美元，預計到2033年將達到404.3億美元，2025年至2033年的複合年成長率為22.54%。這一成長是由對先進基因組研究的需求不斷成長、遺傳疾病患病率上升以及精準醫療的日益普及所驅動的。

遺傳性和慢性疾病的盛行率不斷上升

下一代定序 (NGS) 服務業需求成長的關鍵促進因素之一是全球遺傳性疾病和慢性病負擔的日益加重。癌症、心血管疾病、神經系統疾病和罕見遺傳症候群等疾病的盛行率不斷上升，推動了對先進診斷工具的需求。傳統診斷方法往往無法識別複雜疾病的潛在遺傳病因，而 NGS 可提供全面的基因組訊息，從而實現早期檢測和精準診斷。例如，根據美國疾病管制與預防中心 (CDC) 的數據，十分之六的美國人患有至少一種慢性病，十分之四的人同時患有兩種或兩種以上慢性病。隨著世界各地的醫療保健系統向預防性和精準醫療轉型，對強大、準確且擴充性的測序服務的需求持續飆升。

由於罕見遺傳疾病的複雜性和罕見性，以往診斷難度較大，但如今藉由新一代定序（NGS）技術進行全基因組和EXOME定序，可以有效辨識這些疾病。例如，NGS 可以檢測癌症患者的體細胞突變，有助於制定個人化治療方案，改善患者預後。此外，隨著越來越多的人尋求全面的遺傳資訊以了解疾病風險並指導醫療決策，臨床檢查室、醫院和研究機構正日益成為專業的 NGS服務供應商。預計在預測期內，隨著 NGS 服務逐漸成為全球對抗慢性病和遺傳疾病的重要工具，這一趨勢將進一步增強。

目錄

第1章 分析方法和範圍

第2章執行摘要

第3章 市場因素、趨勢與範圍

  • 市場聯動展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場趨勢與展望
  • 市場促進因素
    • 遺傳和慢性疾病的趨勢日益成長
    • 更加重視品管和安全
  • 市場限制因素分析
    • 實施大規模NGS分析工作流程所面臨的挑戰
    • 單細胞定序的分析挑戰
  • 商業環境分析
    • PESTEL 分析
    • 波特五力分析

第4章 依服務類型進行業務分析

  • 全球次世代定序服務市場按變異分析和服務類型分類
  • 人類基因組定序服務
    • 人類基因體定序服務市場（2021-2033）
  • 單細胞定序服務
    • 單細胞定序服務市場（2021-2033）
  • 微生物基因組定序服務
    • 微生物基因體定序服務市場（2021-2033）
  • 基因調控服務
    • 基因調控服務市場（2021-2033）
    • 小RNA測序服務
    • 晶片測序服務
    • 其他基於基因調控的服務
  • 動植物定序服務
    • 動植物定序服務市場（2021-2033）
  • 其他定序服務
    • 其他定序服務市場（2021-2033 年）

第5章 依工作流程進行業務分析

  • 全球下一代定序服務市場：基於變異分析和工作流程
  • 預測序服務
    • 預測序服務市場（2021-2033）
  • 定序服務
    • 定序服務市場（2021-2033）
  • 數據分析服務
    • 數據分析服務市場（2021-2033）

第6章：依最終用途進行業務分析

  • 全球下一代定序服務市場按變異分析和最終用途分類
  • 大學和其他研究機構
    • 大學及其他研究機構市場（2021-2033 年）
  • 醫院和診所
    • 醫院和診所市場（2021-2033 年）
  • 製藥和生物技術機構
    • 醫藥和生物技術機構市場（2021-2033）
  • 其他
    • 其他市場（2021-2033 年）

第7章：區域商業分析

  • 下一代定序服務市場：按地區分類的市場佔有率（2024 年和 2033 年）
  • 北美洲
    • 北美次世代定序服務市場（2021-2033 年）
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 歐洲次世代定序服務市場（2021-2033）
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
    • 瑞士
  • 亞太地區
    • 亞太地區次世代定序服務市場（2021-2033）
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
    • 新加坡
  • 拉丁美洲
    • 拉丁美洲次世代定序服務市場（2021-2033 年）
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 中東和非洲次世代定序服務市場（2021-2033 年）
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭情勢

  • 公司分類
  • 策略規劃
  • 公司市佔率/市場地位分析（2024 年）
  • 公司簡介/列表
    • Illumina, Inc.
    • Thermo Fisher Scientific Inc.
    • BGI Genomics
    • Eurofins Genomics
    • GENEWIZ
    • Macrogen Inc.
    • QIAGEN NV
    • Agilent Technologies Inc.
    • Revvity, Inc.
    • Twist Bioscience
Product Code: GVR-2-68038-630-1

Next-generation Sequencing Services Market Summary

The global next-generation sequencing services market size was estimated at USD 6.66 billion in 2024 and is anticipated to reach USD 40.43 billion by 2033, expanding at a CAGR of 22.54% from 2025 to 2033. This growth is driven by the increasing demand for advanced genomic research, the rising prevalence of genetic disorders, and the growing adoption of precision medicine.

Increased Prevalence of Genetic and Chronic Diseases

One of the most significant drivers fueling demand in the next-generation sequencing (NGS) services industry is the rising global burden of genetic and chronic diseases. Conditions such as cancer, cardiovascular diseases, neurological disorders, and rare inherited syndromes are increasing in prevalence, prompting a heightened need for advanced diagnostic tools. Traditional diagnostic methods often fail to identify the underlying genetic causes of complex diseases, whereas NGS offers comprehensive genomic insights that enable early detection and precise diagnosis. For instance, according to data from the Centers for Disease Control and Prevention (CDC), 6 out of 10 Americans suffer from at least one chronic illness. At the same time, 4 out of 10 are affected by two or more chronic conditions. As healthcare systems worldwide shift toward preventive and precision medicine, the demand for robust, accurate, and scalable sequencing services continues to surge.

Rare genetic disorders, often undiagnosed due to their complexity and rarity, can now be effectively identified through whole-genome and exome sequencing provided by NGS services. For example, NGS can detect somatic mutations in cancer patients, facilitating the development of personalized treatment plans and improving patient outcomes. Moreover, as more individuals seek comprehensive genetic information to understand disease risks and inform their healthcare decisions, clinical laboratories, hospitals, and research institutions are increasingly becoming specialized NGS service providers. This trend is expected to intensify during the forecast period, positioning NGS services as an indispensable tool in the global fight against chronic and hereditary diseases.

Global Next-Generation Sequencing Services Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the next-generation sequencing services market on the basis of service type, workflow, end use, and region:

  • Service Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Human Genome Sequencing Services
  • Single Cell Sequencing Services
  • Microbial Genome-based Sequencing Services
  • Gene Regulation Services
    • Small RNA Sequencing
    • ChIP Sequencing
    • Other Gene Regulation-based Services
  • Animal & Plant Sequencing Services
  • Other Sequencing Services
  • Workflow Outlook (Revenue, USD Million, 2021 - 2033)
  • Pre-sequencing
  • Sequencing
  • Data Analysis
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Universities & Other Research Entities
  • Hospitals & Clinics
  • Pharma & Biotech Entities
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
    • Switzerland
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
    • Singapore
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Information analysis
    • 1.2.2. Market formulation & data visualization
    • 1.2.3. Data validation & publishing
  • 1.3. Information Procurement
    • 1.3.1. Primary Others
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Market Model
  • 1.7. Objectives
    • 1.7.1. Objective 1
    • 1.7.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Derivers
    • 3.3.1. Increased Prevalence of Genetic and Chronic Diseases
    • 3.3.2. Rising emphasis on quality control and safety
  • 3.4. Market Restraint Analysis
    • 3.4.1. Challenges pertaining to the implementation of large-scale NGS analysis workflows
    • 3.4.2. Analytical challenges in single-cell sequencing
  • 3.5. Business Environment Analysis
    • 3.5.1. PESTEL Analysis
    • 3.5.2. Porter's Five Forces Analysis

Chapter 4. Service Type Business Analysis

  • 4.1. Global Next-Generation Sequencing Services Market: Service Type Movement Analysis
  • 4.2. Human Genome Sequencing Services
    • 4.2.1. Human Genome Sequencing Services Market, 2021 - 2033 (USD Million)
  • 4.3. Single-Cell Sequencing Services
    • 4.3.1. Single-Cell Sequencing Services Market, 2021 - 2033 (USD Million)
  • 4.4. Microbial Genome-based Sequencing Services
    • 4.4.1. Microbial Genome-based Sequencing Services Market, 2021 - 2033 (USD Million)
  • 4.5. Gene Regulation Services
    • 4.5.1. Gene Regulation Services Market, 2021 - 2033 (USD Million)
    • 4.5.2. Small RNA Sequencing Services
      • 4.5.2.1. Small RNA Sequencing Services Market, 2021 - 2033 (USD Million)
    • 4.5.3. Chip Sequencing Services
      • 4.5.3.1. Chip Sequencing Services Market, 2021 - 2033 (USD Million)
    • 4.5.4. Other Gene Regulation-based Service
      • 4.5.4.1. Other Gene Regulation-based Service Market, 2021 - 2033 (USD Million)
  • 4.6. Animal & Plant Sequencing Services
    • 4.6.1. Animal & Plant Sequencing Services Market, 2021 - 2033 (USD Million)
  • 4.7. Other Sequencing Services
    • 4.7.1. Other Sequencing Services Market, 2021 - 2033 (USD Million)

Chapter 5. Workflow Business Analysis

  • 5.1. Global Next-Generation Sequencing Services Market: Workflow Movement Analysis
  • 5.2. Pre Sequencing Service
    • 5.2.1. Pre Sequencing Service Market, 2021 - 2033 (USD Million)
  • 5.3. Sequencing Service
    • 5.3.1. Sequencing Service Market, 2021 - 2033 (USD Million)
  • 5.4. Data Analysis Service
    • 5.4.1. Data Analysis Service Market, 2021 - 2033 (USD Million)

Chapter 6. End Use Business Analysis

  • 6.1. Global Next-Generation Sequencing Services Market: End Use Movement Analysis
  • 6.2. Universities & Other Research Entities
    • 6.2.1. Universities & Other Research Entities Market, 2021 - 2033 (USD Million)
  • 6.3. Hospitals & Clinics
    • 6.3.1. Hospitals & Clinics Market, 2021 - 2033 (USD Million)
  • 6.4. Pharma & Biotech Entities
    • 6.4.1. Pharma & Biotech Entities Market, 2021 - 2033 (USD Million)
  • 6.5. Others
    • 6.5.1. Others Market, 2021 - 2033 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Global Next-Generation Sequencing Services Market Share, By Region, 2024 & 2033
  • 7.2. North America
    • 7.2.1. North America Next-generation sequencing services market, 2021 - 2033 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. Competitive Scenario
      • 7.2.2.3. Regulatory Framework
      • 7.2.2.4. Target Disease Prevalence
      • 7.2.2.5. U.S. Next-generation sequencing services market, 2021 - 2033 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Competitive Scenario
      • 7.2.3.3. Regulatory Framework
      • 7.2.3.4. Target Disease Prevalence
      • 7.2.3.5. Canada Next-generation sequencing services market, 2021 - 2033 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Key Country Dynamics
      • 7.2.4.2. Competitive Scenario
      • 7.2.4.3. Regulatory Framework
      • 7.2.4.4. Target Disease Prevalence
      • 7.2.4.5. Mexico Next-generation sequencing services market, 2021 - 2033 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Next-generation sequencing services market, 2021 - 2033 (USD Million)
    • 7.3.2. Germany
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. Target Disease Prevalence
      • 7.3.2.5. Germany Next-generation sequencing services market, 2021 - 2033 (USD Million)
    • 7.3.3. UK
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Target Disease Prevalence
      • 7.3.3.5. UK Next-generation sequencing services market, 2021 - 2033 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. Target Disease Prevalence
      • 7.3.4.5. France Next-generation sequencing services market, 2021 - 2033 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Competitive Scenario
      • 7.3.5.3. Regulatory Framework
      • 7.3.5.4. Target Disease Prevalence
      • 7.3.5.5. Italy Next-generation sequencing services market, 2021 - 2033 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Competitive Scenario
      • 7.3.6.3. Regulatory Framework
      • 7.3.6.4. Target Disease Prevalence
      • 7.3.6.5. Spain Next-generation sequencing services market, 2021 - 2033 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Competitive Scenario
      • 7.3.7.3. Regulatory Framework
      • 7.3.7.4. Target Disease Prevalence
      • 7.3.7.5. Denmark Next-generation sequencing services market, 2021 - 2033 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Competitive Scenario
      • 7.3.8.3. Regulatory Framework
      • 7.3.8.4. Target Disease Prevalence
      • 7.3.8.5. Sweden Next-generation sequencing services market, 2021 - 2033 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Competitive Scenario
      • 7.3.9.3. Regulatory Framework
      • 7.3.9.4. Target Disease Prevalence
      • 7.3.9.5. Norway Next-generation sequencing services market, 2021 - 2033 (USD Million)
    • 7.3.10. Switzerland
      • 7.3.10.1. Key Country Dynamics
      • 7.3.10.2. Competitive Scenario
      • 7.3.10.3. Regulatory Framework
      • 7.3.10.4. Target Disease Prevalence
      • 7.3.10.5. Switzerland Next-generation sequencing services market, 2021 - 2033 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Next-generation sequencing services market, 2021 - 2033 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Target Disease Prevalence
      • 7.4.2.5. Japan Next-generation sequencing services market, 2021 - 2033 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Target Disease Prevalence
      • 7.4.3.5. China Next-generation sequencing services market, 2021 - 2033 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. Target Disease Prevalence
      • 7.4.4.5. India Next-generation sequencing services market, 2021 - 2033 (USD Million)
    • 7.4.5. South Korea
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Target Disease Prevalence
      • 7.4.5.5. South Korea Next-generation sequencing services market, 2021 - 2033 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Target Disease Prevalence
      • 7.4.6.5. Australia Next-generation sequencing services market, 2021 - 2033 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. Target Disease Prevalence
      • 7.4.7.5. Thailand Next-generation sequencing services market, 2021 - 2033 (USD Million)
    • 7.4.8. Singapore
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Competitive Scenario
      • 7.4.8.3. Regulatory Framework
      • 7.4.8.4. Target Disease Prevalence
      • 7.4.8.5. Singapore Next-generation sequencing services market, 2021 - 2033 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Next-generation sequencing services market, 2021 - 2033 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Target Disease Prevalence
      • 7.5.2.5. Brazil Next-generation sequencing services market, 2021 - 2033 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Target Disease Prevalence
      • 7.5.3.5. Argentina Next-generation sequencing services market, 2021 - 2033 (USD Million)
  • 7.6. MEA
    • 7.6.1. MEA Next-generation sequencing services market, 2021 - 2033 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Target Disease Prevalence
      • 7.6.2.5. South Africa Next-generation sequencing services market, 2021 - 2033 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Target Disease Prevalence
      • 7.6.3.5. Saudi Arabia Next-generation sequencing services market, 2021 - 2033 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Target Disease Prevalence
      • 7.6.4.5. UAE Next-generation sequencing services market, 2021 - 2033 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Target Disease Prevalence
      • 7.6.5.5. Kuwait Next-generation sequencing services market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market/Position Share Analysis, 2024
  • 8.4. Company Profiles/Listing
    • 8.4.1. Illumina, Inc.
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Thermo Fisher Scientific Inc.
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. BGI Genomics
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Eurofins Genomics
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. GENEWIZ
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Macrogen Inc.
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. QIAGEN N.V.
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. Agilent Technologies Inc.
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Revvity, Inc.
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. Twist Bioscience
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List Of Secondary Sources
  • Table 2 List Of Abbreviations
  • Table 3 Global next-generation sequencing services market by service type, 2021 - 2033 (USD million)
  • Table 4 Global next-generation sequencing services market by workflow, 2021 - 2033 (USD million)
  • Table 5 Global next-generation sequencing services market by end use, 2021 - 2033 (USD million)
  • Table 6 North America next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 7 North America next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 8 North America next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 9 North America next-generation sequencing services market estimates & forecasts, by country, 2021 - 2033 (USD Million)
  • Table 10 U.S. next-generation sequencing services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 11 U.S. next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 12 U.S. next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 13 Canada next-generation sequencing services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 14 Canada next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 15 Canada next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 16 Mexico next-generation sequencing services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 17 Mexico next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 18 Mexico next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 19 Europe next-generation sequencing services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 20 Europe next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 21 Europe next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 22 Europe next-generation sequencing services market estimates & forecasts, by country, 2021 - 2033 (USD Million)
  • Table 23 Germany next-generation sequencing services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 24 Germany next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 25 Germany next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 26 UK next-generation sequencing services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 27 UK next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 28 UK next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 29 France next-generation sequencing services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 30 France next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 31 France next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 32 Italy next-generation sequencing services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 33 Italy next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 34 Italy next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 35 Spain next-generation sequencing services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 36 Spain next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 37 Spain next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 38 Denmark next-generation sequencing services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 39 Denmark next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 40 Denmark next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 41 Sweden next-generation sequencing services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 42 Sweden next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 43 Sweden next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 44 Norway next-generation sequencing services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 45 Norway next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 46 Norway next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 47 Switzerland next-generation sequencing services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 48 Switzerland next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 49 Switzerland next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific next-generation sequencing services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 51 Asia Pacific next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 52 Asia Pacific next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 53 Asia Pacific next-generation sequencing services market estimates & forecasts, by country, 2021 - 2033 (USD Million)
  • Table 54 Japan next-generation sequencing services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 55 Japan next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 56 Japan next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 57 China next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 58 China next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 59 China next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 60 India next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 61 India next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 62 India next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 63 Australia next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 64 Australia next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 65 Australia next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 66 South Korea next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 67 South Korea next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 68 South Korea next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 69 Thailand next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 70 Thailand next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 71 Thailand next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 72 Singapore next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 73 Singapore next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 74 Singapore next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 75 Latin America next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 76 Latin America next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 77 Latin America next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 78 Latin America next-generation sequencing services market estimates & forecasts, by country, 2021 - 2033 (USD Million)
  • Table 79 Brazil next-generation sequencing services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 80 Brazil next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 81 Brazil next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 82 Argentina next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 83 Argentina next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 84 Argentina next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 85 MEA next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 86 MEA next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 87 MEA next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 88 MEA next-generation sequencing services market estimates & forecasts, by country, 2021 - 2033 (USD Million)
  • Table 89 South Africa next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 90 South Africa next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 91 South Africa next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 92 Saudi Arabia next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 93 Saudi Arabia next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 94 Saudi Arabia next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 95 UAE next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 96 UAE next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 97 UAE next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 98 Kuwait next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 99 Kuwait next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 100 Kuwait next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 101 Participant's Overview

List of Figures

  • Fig. 1 Market Others process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary Others pattern
  • Fig. 4 Market Others approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market summary, 2024 (USD Million)
  • Fig. 9 Market segmentation & scope
  • Fig. 10 Market driver impact
  • Fig. 11 Market restraint impact
  • Fig. 12 Penetration & growth prospect mapping
  • Fig. 13 Porter's analysis
  • Fig. 14 SWOT analysis
  • Fig. 15 Next-generation sequencing services market: Service type outlook and key takeaways
  • Fig. 16 Next-generation sequencing services market: Service type movement analysis
  • Fig. 17 Human genome sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 18 Single-cell sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 19 Microbial genome-based sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 20 Gene regulation services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 21 Small RNA sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 22 Chip sequencing service market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 23 Other gene regulation-based service market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 24 Animal & plant sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 25 Other sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 26 Next-generation sequencing services market: Workflow outlook and key takeaways
  • Fig. 27 Next-generation sequencing services market: Workflow movement analysis
  • Fig. 28 Pre-sequenceing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 29 Sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 30 Data analysis service market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 31 Next-generation sequencing services market: End use outlook and key takeaways
  • Fig. 32 Next-generation sequencing services market: End use movement analysis
  • Fig. 33 Universities & other research entities, 2021 - 2033 (USD Million)
  • Fig. 34 Hospitals & clinics, 2021 - 2033 (USD Million)
  • Fig. 35 Pharma & biotech entities, 2021 - 2033 (USD Million)
  • Fig. 36 Other end use, 2021 - 2033 (USD Million)
  • Fig. 37 Global next-generation sequencing services market: Regional outlook and key takeaways
  • Fig. 38 North America next-generation sequencing services market, 2021 - 2033 (USD Million)
  • Fig. 39 U.S. key country dynamics
  • Fig. 40 U.S. next-generation sequencing services market, 2021 - 2033 (USD Million)
  • Fig. 41 Canada key country dynamics
  • Fig. 42 Canada next-generation sequencing services market, 2021 - 2033 (USD Million)
  • Fig. 43 Mexico key country dynamics
  • Fig. 44 Mexico next-generation sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 45 Europe next-generation sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 46 Germany key country dynamics
  • Fig. 47 Germany next-generation sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 48 France key country dynamics
  • Fig. 49 France next-generation sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 50 UK key country dynamics
  • Fig. 51 UK next-generation sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 52 Italy key country dynamics
  • Fig. 53 Italy next-generation sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 54 Spain key country dynamics
  • Fig. 55 Spain next-generation sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 56 Denmark key country dynamics
  • Fig. 57 Denmark next-generation sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 58 Sweden key country dynamics
  • Fig. 59 Sweden next-generation sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 60 Norway key country dynamics
  • Fig. 61 Norway next-generation sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 62 Switzerland key country dynamics
  • Fig. 63 Switzerland next-generation sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 64 Asia-Pacific next-generation sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 65 China key country dynamics
  • Fig. 66 China next-generation sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 67 India key country dynamics
  • Fig. 68 India next-generation sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 69 South Korea key country dynamics
  • Fig. 70 South Korea next-generation sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 71 Japan key country dynamics
  • Fig. 72 Japan next-generation sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 73 Australia key country dynamics
  • Fig. 74 Australia next-generation sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 75 Thailand key country dynamics
  • Fig. 76 Thailand next-generation sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 77 Singapore key country dynamics
  • Fig. 78 Singapore next-generation sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 79 Latin America next-generation sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 80 Brazil key country dynamics
  • Fig. 81 Brazil next-generation sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 82 Argentina key country dynamics
  • Fig. 83 Argentina next-generation sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 84 MEA next-generation sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 85 South Africa key country dynamics
  • Fig. 86 South Africa next-generation sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 87 Saudi Arabia key country dynamics
  • Fig. 88 Saudi Arabia next-generation sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 89 UAE key country dynamics
  • Fig. 90 UAE next-generation sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 91 Kuwait key country dynamics
  • Fig. 92 Kuwait next-generation sequencing services market estimates and forecast, 2021 - 2033 (USD Million)